2.Phenylethanoid glycosides distribution in medicinal plants of Gesneriaceae.
Zhen-Fang BAI ; Xiao-Qin WANG ; Pei-Gen XIAO ; Yong LIU
China Journal of Chinese Materia Medica 2013;38(24):4267-4270
To investigate the role of distribution and phylogeny of phenylethanoid glycoside in medicinal plants of Gesneriaceae, five phenylpropanoid glycosides, acteoside, paraboside B, isonuomioside A, paraboside II, and paraboside III were quantitatively determined in 12 species of Gesneriaceae by HPLC. The existence and content of these compounds were analyzed. The results showed that phenylethanoid glycosides were found in the most of those plants, but the kind of phenylethanoid glycosides varied in different species. Acteoside distribute in most of this plant group, paraboside B, isonuomioside A, paraboside II, and paraboside III were rare in those plants. The results of this study support morphological viewpoint that Trib. Trichosporeae is more developmental than Trib. Didymocarpeae.
Glucosides
;
chemistry
;
metabolism
;
Magnoliopsida
;
metabolism
;
Phenylethyl Alcohol
;
chemistry
;
Plants, Medicinal
;
metabolism
3.Review of research and development and significant effect of Hippophae rhamnoides.
Yong LIU ; Yong-Shan LIAN ; Ying-Li WANG ; Min-Hui LI ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2014;39(9):1547-1552
Hippophae rhamnoides is one of the most representative economy crops for its wide uses of biological diversity and abundance of resource. As the key healthy food development and ecology protection, H. rhamnoides has been developed widely. Meanwhile, the development of H. rhamnoides has obtained great achievements. Nowadays, H. rhamnoides is still a necessary economy crop, while it has great influence on ecology protection. This paper discussed the phytochemistry, pharmacology, clinical application and product development, and propounded some suggestions for future research and economy development to get comprehensive benefit of H. rhamnoides and to serve for well-off society.
Biomedical Research
;
methods
;
trends
;
Drugs, Chinese Herbal
;
chemistry
;
therapeutic use
;
Flavonoids
;
chemistry
;
therapeutic use
;
Hippophae
;
chemistry
;
Humans
;
Molecular Structure
;
Phytotherapy
;
methods
;
trends
;
Polyphenols
;
chemistry
;
therapeutic use
4.Studies on genetic relationship of Dioscorea.
Han-han HUANG ; Xia LI ; Wen-yuan GAO ; Pei-gen XIAO
China Journal of Chinese Materia Medica 2015;40(17):3470-3479
Based on the results of the morphologic studies on genus Dioscorea, the paper summarized the entire chemical constituent that isolated from this genus and analyzed it with the methods of chemotaxonomy. The rules of the chemical constituent and pharmacodynamic effects were analyzed. Seventeen species which belong to Sect. Stenophora Uline of Dioscorea contain steroidal sapogenin. Other species with different main components such as polysaccharide and tannin have have different effects. This chemotaxonomic view point will conduce to establish a phylogeny of the genus Dioscorea.
Animals
;
China
;
Dioscorea
;
chemistry
;
classification
;
genetics
;
growth & development
;
Humans
;
Phylogeny
;
Plant Extracts
;
chemistry
;
pharmacology
5.Essentials of pharmacophylogeny: knowledge pedigree, epistemology and paradigm shift.
Da-cheng HAO ; Pei-gen XIAO ; Li-wei LIU ; Yong PENG ; Chun-nian HE
China Journal of Chinese Materia Medica 2015;40(17):3335-3342
Chinese materia medica resource (CMM resource) is the foundation of the development of traditional Chinese medicine. In the study of sustainable utilization of CMM resource, adopting innovative theory and method to find new CMM resource is one of hotspots and always highlighted. Pharmacophylogeny interrogates the phylogenetic relationship of medicinal organisms (especially medicinal plants), as well as the intrinsic correlation of morphological taxonomy, molecular phylogeny, chemical constituents, and therapeutic efficacy (ethnopharmacology and pharmacological activity). This new discipline may have the power to change the way we utilize medicinal plant resources and develop plant-based drugs. Phylogenomics is the crossing of evolutionary biology and genomics, in which genome data are utilized for evolutionary reconstructions. Phylogenomics can be integrated into the flow chart of drug discovery and development, and extends the field of pharmacophylogeny at the omic level, thus the concept of pharmacophylogenomics could be redefined in the context of plant pharmaceutical resources. This contribution gives a brief discourse of knowledge pedigree of pharmacophylogeny, epistemology and paradigm shift, highlighting the theoretical and practical values of pharmacophylogenomics. Many medicinally important tribes and genera, such as Clematis, Pulsatilla, Anemone, Cimicifugeae, Nigella, Delphinieae, Adonideae, Aquilegia, Thalictrum, and Coptis, belong to Ranunculaceae family. Compared to other plant families, Ranunculaceae has the most species that are recorded in China Pharmacopoeia (CP) 2010. However, many Ranunculaceae species, e. g., those that are closely related to CP species, as well as those endemic to China, have not been investigated in depth, and their phylogenetic relationship and potential in medicinal use remain elusive. As such, it is proposed to select Ranunculaceae to exemplify the utility of pharmacophylogenomics and to elaborate the new concept empirically. It is argued that phylogenetic and evolutionary relationship of medicinally important tribes and genera within Ranunculaceae could be elucidated at the genomic, transcriptomic, and metabolomic levels, from which the intrinsic correlation between medicinal plant genotype and metabolic phenotype, and between genetic diversity and chemodivesity of closely related taxa, could be revealed. This proof-of-concept study regards pharmacophylogenomics as the updated version of pharmacophylogeny and would enrich the intension and spread the extension of pharmacophylogeny. The interdisciplinary knowledge and techniques will be integrated in the proposed study to promote development of CMM resource discipline and to boost sustainable development of Chinese medicinal plant resources.
China
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Knowledge
;
Medicine, Chinese Traditional
;
Phylogeny
;
Plants, Medicinal
;
chemistry
;
classification
;
genetics
6.Identification of EST-SSRs in Taxus cuspidata based on high-throughput sequencing.
Qiong WU ; Xiao-Qun DUAN ; Xu CHEN ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2012;37(24):3728-3733
OBJECTIVETaxus species are highly valued for the production of taxol. Based on high-throughput sequenceing, EST-SSRs were explored and studied in the transcriptome of Taxus cuspidata.
METHODT cuspidata leaf cDNA was extracted and sequenced by 454 GS FLX Titanium. High-quality sequences were assembled using Newbler Assembler Software, which produced unique sequences. SSRs motif was explored using simple sequence repeat identification tool (Perl Script). Primers were designed using PRIMER3.
RESULTA total of 81 148 high-quality reads from the needles of T. cuspidata were produced using the Roche GS FLX Titanium system. A total of 20 557 unique sequences were obtained. There were 753 simple sequence repeat motifs identified. Primers of PCR were obtained for 519 EST-SSRs, randomly selected cloning sequencing revealed that 87.5% of ESTs were the same as the results of Sanger sequencing.
CONCLUSIONThe results provide the first EST-SSRs collection in Taxus and are essential for future efforts of gene discovery, functional genomics, and genome annotation in related species.
DNA Primers ; genetics ; Expressed Sequence Tags ; Gene Expression Profiling ; methods ; Gene Expression Regulation, Plant ; High-Throughput Nucleotide Sequencing ; methods ; Microsatellite Repeats ; genetics ; Taxus ; genetics ; Transcriptome ; genetics
7.Studies on Polysaccharides in Different Development Stages of Armillaria mellea (Vahl.: Fr.) Quel.
Xiao-Mei CHEN ; Shun-Xing GUO ; Qiu-Ying WANG ; Pei-Gen XIAO
China Journal of Chinese Materia Medica 2001;26(6):381-384
Objective: To study the polysaccharides in different development stages of Armillaria mellea.Method: Polysaccharides in rhizomorph, fruit-body, mycelia and its fermenting liquor of A. mellea were extracted, isolated and purified. The properties contents, molar ratio and molecular weight of the polysaccharides were determined by IR spectra, HPLC, GPC and gel chromatography. Result:The polysaccharides in mycelia and its fermenting liquor contained only glucose, the sugar contents were 9.00% in mycelia and 0.87 g*(100 ml)-1in fermenting liquor respectively. The polysaccharides in both rhizomorph and fruit-body consisted of glucose and xylose, and the molar ratio was 1∶14 in rhizomorph and 1∶10 in fruit-body respectively; the polysaccharide contents were 1.12% in rhizomorph and 2.27% in fruit-body. The molecular weight of these polysaccharides was about 10 000~70 000.Conclusion: The experimental results supply important scientific data for developing A. mellea as a medicine.
8.Pharmaphylogeny vs. pharmacophylogenomics: molecular phylogeny, evolution and drug discovery.
Da-cheng HAO ; Pei-gen XIAO ; Ming LIU ; Yong PENG ; Chun-nian HE
Acta Pharmaceutica Sinica 2014;49(10):1387-1394
With the surge of high-throughput sequencing technology, it is becoming popular to perform the phylogenetic study based on genomic data. A bundle of new terms is emerging, such as phylogenomics, pharmacophylogenomics and phylotranscriptomics, which are somewhat overlapping with pharmaphylogeny. Phylogenomics is the crossing of evolutionary biology and genomics, in which genome data are utilized for evolutionary reconstructions. Pharmaphylogeny, advocated by Prof. Pei-gen Xiao since 1980s, focuses on the phylogenetic relationship of medicinal plants and is thus nurtured by molecular phylogeny, chemotaxonomy and bioactivity studies. Phylogenomics can be integrated into the flow chart of drug discovery and development, and extend the field of pharmaphylogeny at the omic level, thus the concept of pharmacophylogenomics could be redefined. This review gives a brief analysis of the association and the distinguished feature of the pharmaphylogeny related terms, in the context of plant-based drug discovery and sustainable utilization of pharmaceutical resource.
Drug Discovery
;
Pharmacogenetics
;
Phylogeny
;
Plants, Medicinal
;
chemistry
;
genetics
9.Study on content determination of alkaloids and HPLC fingerprint of "Jianlian" Nelumbinis Plumula.
Jiu-shi LIU ; Yan-feng HE ; Shi-man GAO ; Ben-gang ZHANG ; Hai-tao LIU ; Pei-gen XIAO
China Journal of Chinese Materia Medica 2015;40(16):3239-3244
This study is to determine the content of three alkaloids and establish the HPLC fingerprint of "Jianlian" Nelumbinis Plumula. The HPLC method of content determination was as follows: Thermo C18 (4. 6 mm x 250 mm, 5 μm) was conducted with acetonitrile-sodium dodecyl sulfonate solution-acetic acid (56: 43: 1) at a flow rate of 1.0 mL x min(-1). The monitoring wavelength was set at 282 nm and the column temperature was 35 degrees C. The method of HPLC fingerprint was as follows: Agilent ZORBAX SB-Aq C18 (4.6 mm x 250 mm, 5 μm) was conducted with gradient elution of methanol and water at a flow rate of 0.8 mL x min(-1), the monitoring wavelength was set at 282 nm and the column temperature was 35 degrees C. Similarities evaluation and hierarchical clustering analysis were applied to demonstrate the variability of 12 batches of "Jianlian" Nelumbinis Plumula samples. The results demonstrated that 11 batches showed good similarity on chemical constituents. The method could well display the chemical information of "Jianlian" Nelumbinis Plumula. It was simple, reliable and could be used for the chemical quality control of "Jianlian" Nelumbinis Plumula.
Alkaloids
;
analysis
;
Chromatography, High Pressure Liquid
;
methods
;
Drugs, Chinese Herbal
;
analysis
;
Nelumbo
;
chemistry
;
Quality Control
;
Seeds
;
chemistry
10.Progress of taxonomic study on Fritillaria (Liliaceae) medicinal plant.
Shu-jun WANG ; Wen-yuan GAO ; Jing-lin YU ; Pei-gen XIAO
China Journal of Chinese Materia Medica 2007;32(16):1609-1614
In this review, we described the taxonomic study of the Fritillaria medicinal plant in the recent years. The taxonomic study of the Fritillaria medicinal plant was carried out from three main aspects: the traditional morphological character, the characteristic constituents of the plant and genotyping and species identification of Fritillaria by DNA chips. By comparison, we concluded that the DNA chip technology can provide a rapid, high throughput for genotyping and quality assurance of the plant species verification. It is the most prosperous method of species identification of the plant.
Cevanes
;
isolation & purification
;
Flowers
;
anatomy & histology
;
chemistry
;
genetics
;
Fritillaria
;
anatomy & histology
;
classification
;
genetics
;
Genotype
;
Oligonucleotide Array Sequence Analysis
;
Plant Leaves
;
anatomy & histology
;
chemistry
;
genetics
;
Plants, Medicinal
;
anatomy & histology
;
classification
;
genetics